Lannutti and colleagues unexpectedly found that expressing TPO-R at lower than normal physiological levels in Mpl−/− mice led to elevated plasma TPO levels, driving excessive megakaryopoiesis and thrombocytosis (94). Here, TPO is linked to thrombocytosis disease.